ML18037A541: Difference between revisions

From kanterella
Jump to navigation Jump to search
(Created page by program invented by StriderTol)
(Created page by program invented by StriderTol)
Line 16: Line 16:


=Text=
=Text=
{{#Wiki_filter:}}
{{#Wiki_filter:From:Carolyn HaassTo:Docket, HearingCc:Carolyn Haass; Artha Petermann
 
==Subject:==
[External_Sender] January 23, 2018 Commission Hearing Transcript ReviewDate:Monday, February 05, 2018 12:06:12 PMAttachments:image001.pngTo Whom It May Concern: NWMI has reviewed the transcript and did not find any transcription errors that were material to thesubstance of the testimony/statements. If you have any questions, please feel free to contact me. Regards, Carolyn HaassNorthwest Medical Isotopes, LLCChief Operating Officer l Vice President509-430-6921carolyn.haass@nwmedicalisotopes.comwww.nwmedicalisotopes.com
}}

Revision as of 06:57, 20 April 2018

Email from Carolyn Haass Advising That Northwest Medical Isotopes, LLC Does Not Have Any Corrections for the Transcript of the Mandatory Hearing
ML18037A541
Person / Time
Site: Northwest Medical Isotopes
Issue date: 02/05/2018
From: Haass C
Northwest Medical Isotopes
To:
NRC/OCM
References
50-609-CP, Construction Permit Mndtry Hrg
Download: ML18037A541 (1)


Text

From:Carolyn HaassTo:Docket, HearingCc:Carolyn Haass; Artha Petermann

Subject:

[External_Sender] January 23, 2018 Commission Hearing Transcript ReviewDate:Monday, February 05, 2018 12:06:12 PMAttachments:image001.pngTo Whom It May Concern: NWMI has reviewed the transcript and did not find any transcription errors that were material to thesubstance of the testimony/statements. If you have any questions, please feel free to contact me. Regards, Carolyn HaassNorthwest Medical Isotopes, LLCChief Operating Officer l Vice President509-430-6921carolyn.haass@nwmedicalisotopes.comwww.nwmedicalisotopes.com